Clinical Oncology: If you treat lung cancer, you probably select a drug regimen for your patients based largely on the outcomes of large, randomized clinical trials. But those trials may not be valid for a significant percentage of your patient base—women, minorities and the elderly. In a study released at the recent 14th World Conference […]
Fiercebiotech: There’s a longstanding problem with clinical trials for cancer drugs which has been nagging regulators and developers for years. Historically, only a small segment of the minority community ever gets enrolled in the studies, even though cancer claims a large share of minority lives. So pharma giant Eli Lilly ($LLY) set out to systematically change the […]
By RICK NAUERT PHD Senior News Editor Psychcentral: A new study examined the effectiveness of a motivational counseling approach to treat substance abuse among African-Americans. The study found that African-American women benefited from the approach as they were more likely than men to continue counseling—however, their substance abuse issues continued. The study compared two clinical approaches to treating […]
By Elizabeth Fernandez – It’s a matter of fairness: members of all ethnic groups should have the opportunity to participate in clinical trials. And it’s a matter of soundness, too: medical advancements must be tested in as many different people with as many different genetic makeups as possible. Federally-funded research requires the inclusion of minorities and […]
© 2024 National Health Index, LLC. All Rights Reserved.